发明名称 |
HIGH-STRENGTH TESTOSTERONE UNDECANOATE COMPOSITIONS |
摘要 |
The present disclosure is drawn to pharmaceutical compositions and oral dosage capsules containing testosterone undecanoate, as well as related methods. The capsule includes a capsule shell and a capsule fill. The capsule fill can include a solubilizer and about 14 wt % to about 35 wt % testosterone undecanoate based on the total capsule fill. The oral dosage capsule is such that when a single oral administration to a male subject of one or more capsules with a total testosterone undecanoate daily dose of about 350 mg to about 650 mg it provides a ratio of serum testosterone Cmax to serum testosterone Cave of about 2.7 or less. In yet another embodiment, a method for providing a serum concentration of testosterone within a target serum testosterone concentration Cave range for a male subject is provided. |
申请公布号 |
US2015320765(A1) |
申请公布日期 |
2015.11.12 |
申请号 |
US201514801674 |
申请日期 |
2015.07.16 |
申请人 |
Lipocine Inc. |
发明人 |
Giliyar Chandrashekar;Chickmath Basawaraj;Nachiappan Chidambaram;Patel Mahesh V.;Venkateshwaran Srinivansan |
分类号 |
A61K31/568;A61K9/48 |
主分类号 |
A61K31/568 |
代理机构 |
|
代理人 |
|
主权项 |
1. A pharmaceutical composition comprising from about 14 weight % (wt %) to about 35 wt % testosterone undecanoate and a pharmaceutically acceptable carrier, said testosterone undecanoate being not fully dissolved at room temperature. |
地址 |
Salt Lake City UT US |